Early combination therapy of COVID-19 in high-risk patients
2023 · Infection · 37 citations
https://doi.org/10.1007/s15010-023-02125-5
T
Tessa Hattenhauer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
123
Citations
5
h-index
5
i10-index
Tessa Hattenhauer is an academic researcher from University Hospital Bonn. The author has contributed to research in topics: COVID-19 Clinical Research Studies & Long-Term Effects of COVID-19 & Cancer Immunotherapy and Biomarkers. The author has an h-index of 5, co-authored 12 publications.
ORCID: 0009-0001-3320-8815Papers by this author
works2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies
2025 · The Lancet Regional Health - Europe · 15 citations
https://doi.org/10.1016/j.lanepe.2025.101214
Retrospective analysis of 300 microbial cell-free DNA sequencing results in routine blood stream infection diagnostics
2025 · Frontiers in Cellular and Infection Microbiology · 4 citations
https://doi.org/10.3389/fcimb.2025.1504262
Safety and efficacy of helical tomotherapy following lung-sparing surgery in locally advanced malignant pleural mesothelioma
2023 · Strahlentherapie und Onkologie · 3 citations
https://doi.org/10.1007/s00066-023-02174-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat